{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T17:40:41Z","timestamp":1790185241481,"version":"4.1.0"},"reference-count":40,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2014,11,1]],"date-time":"2014-11-01T00:00:00Z","timestamp":1414800000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,11,1]],"date-time":"2014-11-01T00:00:00Z","timestamp":1414800000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100006751","name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red de Salud Mental","doi-asserted-by":"publisher","award":["RETICS RD06\/0011"],"award-info":[{"award-number":["RETICS RD06\/0011"]}],"id":[{"id":"10.13039\/501100006751","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008061","name":"Fundaci\u00f3n Mutua Madrile\u00f1a","doi-asserted-by":"publisher","award":["S2010\/BMD-2422 AGES"],"award-info":[{"award-number":["S2010\/BMD-2422 AGES"]}],"id":[{"id":"10.13039\/100008061","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"publisher","award":["242114"],"award-info":[{"award-number":["242114"]}],"id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"publisher","award":["602478"],"award-info":[{"award-number":["602478"]}],"id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"publisher","award":["603196"],"award-info":[{"award-number":["603196"]}],"id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"publisher","award":["FP7-HEALTH 241909"],"award-info":[{"award-number":["FP7-HEALTH 241909"]}],"id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008062","name":"Fundaci\u00f3n Alicia Koplowitz","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003329","name":"Ministerio de Econom\u00eda y Competitividad","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003329","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaacap.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Academy of Child & Adolescent Psychiatry"],"published-print":{"date-parts":[[2014,11]]},"DOI":"10.1016\/j.jaac.2014.08.009","type":"journal-article","created":{"date-parts":[[2014,9,2]],"date-time":"2014-09-02T18:13:16Z","timestamp":1409681596000},"page":"1179-1190.e4","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":72,"title":["Second-Generation Antipsychotic Use in Children and Adolescents: A Six-Month Prospective Cohort Study in Drug-Na\u00efve Patients"],"prefix":"10.1016","volume":"53","author":[{"given":"Celso","family":"Arango","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miriam","family":"Gir\u00e1ldez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica","family":"Merch\u00e1n-Naranjo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inmaculada","family":"Baeza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josefina","family":"Castro-Fornieles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose-Angel","family":"Alda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmen","family":"Mart\u00ednez-Cantarero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmen","family":"Moreno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pilar","family":"de Andr\u00e9s","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Cuerda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"de la Serna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph U.","family":"Correll","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Fraguas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mara","family":"Parellada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaac.2014.08.009_bib1","doi-asserted-by":"crossref","first-page":"2323","DOI":"10.1038\/oby.2008.351","article-title":"Will all Americans become overweight or obese? Estimating the progression and cost of the US obesity epidemic","volume":"16","author":"Wang","year":"2008","journal-title":"Obesity (Silver Spring)"},{"key":"10.1016\/j.jaac.2014.08.009_bib2","doi-asserted-by":"crossref","first-page":"596","DOI":"10.2337\/diacare.27.2.596","article-title":"Consensus development conference on antipsychotic drugs and obesity and diabetes","volume":"27","year":"2004","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jaac.2014.08.009_bib3","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1097\/chi.0b013e31815b5cb1","article-title":"Antipsychotic use in children and adolescents: minimizing adverse effects to maximize outcomes","volume":"47","author":"Correll","year":"2008","journal-title":"J\u00a0Am Acad Child Adolesc Psychiatry"},{"key":"10.1016\/j.jaac.2014.08.009_bib4","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1001\/jama.2009.1549","article-title":"Cardiometabolic risk of second-generation antipsychotic medications during first-time use in children and adolescents","volume":"302","author":"Correll","year":"2009","journal-title":"JAMA"},{"key":"10.1016\/j.jaac.2014.08.009_bib5","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/j.euroneuro.2010.07.002","article-title":"Efficacy and safety of second-generation antipsychotics in children and adolescents with psychotic and bipolar spectrum disorders: comprehensive review of prospective head-to-head and placebo-controlled comparisons","volume":"21","author":"Fraguas","year":"2011","journal-title":"Eur Neuropsychopharmacol"},{"key":"10.1016\/j.jaac.2014.08.009_bib6","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.4088\/JCP.v69n0717","article-title":"Metabolic and hormonal side effects in children and adolescents treated with second-generation antipsychotics","volume":"69","author":"Fraguas","year":"2008","journal-title":"J\u00a0Clin Psychiatry"},{"key":"10.1016\/j.jaac.2014.08.009_bib7","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1176\/appi.ajp.2008.08050756","article-title":"Double-blind comparison of first- and second-generation antipsychotics in early-onset schizophrenia and schizo-affective disorder: findings from the Treatment of Early-Onset Schizophrenia Spectrum Disorders (TEOSS) study","volume":"165","author":"Sikich","year":"2008","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.jaac.2014.08.009_bib8","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.schres.2006.09.025","article-title":"Cardiovascular and Metabolic Risk in Outpatients with Schizophrenia Treated with Antipsychotics: results of the CLAMORS Study","volume":"90","author":"Bobes","year":"2007","journal-title":"Schizophr Res"},{"key":"10.1016\/j.jaac.2014.08.009_bib9","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1038\/nrendo.2011.156","article-title":"Metabolic and cardiovascular adverse effects associated with antipsychotic drugs","volume":"8","author":"De Hert","year":"2012","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/j.jaac.2014.08.009_bib10","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1176\/appi.ajp.162.6.1217","article-title":"Cost-effective screening for the metabolic syndrome in patients treated with second-generation antipsychotic medications","volume":"162","author":"Straker","year":"2005","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.jaac.2014.08.009_bib11","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1007\/s00787-009-0749-5","article-title":"Olanzapine compared to quetiapine in adolescents with a first psychotic episode","volume":"18","author":"Arango","year":"2009","journal-title":"Eur Child Adolesc Psychiatry"},{"key":"10.1016\/j.jaac.2014.08.009_bib12","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.chc.2005.08.007","article-title":"Recognizing and monitoring adverse events of second-generation antipsychotics in children and adolescents","volume":"15","author":"Correll","year":"2006","journal-title":"Child Adolesc Psychiatr Clin N Am"},{"key":"10.1016\/j.jaac.2014.08.009_bib13","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.jpeds.2007.09.010","article-title":"Metabolic syndrome in childhood predicts adult metabolic syndrome and type 2 diabetes mellitus 25 to 30 years later","volume":"152","author":"Morrison","year":"2008","journal-title":"J\u00a0Pediatr"},{"key":"10.1016\/j.jaac.2014.08.009_bib14","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1161\/01.CIR.99.11.1471","article-title":"Relation of weight and rate of increase in weight during childhood and adolescence to body size, blood pressure, fasting insulin, and lipids in young adults. The Minneapolis Children's Blood Pressure Study","volume":"99","author":"Sinaiko","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/j.jaac.2014.08.009_bib15","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1056\/NEJMoa035698","article-title":"Relation of serial changes in childhood body-mass index to impaired glucose tolerance in young adulthood","volume":"350","author":"Bhargava","year":"2004","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jaac.2014.08.009_bib16","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1056\/NEJMoa1006992","article-title":"Adolescent BMI trajectory and risk of diabetes versus coronary disease","volume":"364","author":"Tirosh","year":"2011","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jaac.2014.08.009_bib17","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/j.atherosclerosis.2005.06.016","article-title":"Obesity in youth is\u00a0not an independent predictor of carotid IMT in adulthood. The\u00a0Cardiovascular Risk in Young Finns Study","volume":"185","author":"Juonala","year":"2006","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jaac.2014.08.009_bib18","doi-asserted-by":"crossref","first-page":"2277","DOI":"10.1001\/jama.290.17.2277","article-title":"Cardiovascular risk factors in childhood and carotid artery intima-media thickness in adulthood: the Cardiovascular Risk in Young Finns Study","volume":"290","author":"Raitakari","year":"2003","journal-title":"JAMA"},{"key":"10.1016\/j.jaac.2014.08.009_bib19","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1001\/archpsyc.63.6.679","article-title":"National trends in the outpatient treatment of children and adolescents with antipsychotic drugs","volume":"63","author":"Olfson","year":"2006","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.jaac.2014.08.009_bib20","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1001\/archgenpsychiatry.2012.647","article-title":"National trends in the office-based treatment of children, adolescents, and adults with antipsychotics","volume":"69","author":"Olfson","year":"2012","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.jaac.2014.08.009_bib21","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/j.euroneuro.2009.04.008","article-title":"Antipsychotics in children and adolescents: increasing use, evidence for efficacy and safety concerns","volume":"19","author":"Vitiello","year":"2009","journal-title":"Eur Neuropsychopharmacol"},{"key":"10.1016\/j.jaac.2014.08.009_bib22","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1016\/j.euroneuro.2011.04.001","article-title":"Second generation antipsychotics (SGAs) for non-psychotic disorders in children and adolescents: a review of the randomized controlled studies","volume":"21","author":"Zuddas","year":"2011","journal-title":"Eur Neuropsychopharmacol"},{"key":"10.1016\/j.jaac.2014.08.009_bib23","unstructured":"Agency for Healthcare Research and Quality (AHRQ). Comparative effectiveness of first and second generation antipsychotics in\u00a0the pediatric and young adult populations. 2010. Available at: http:\/\/effectivehealthcare.ahrq.gov\/ehc\/products\/147\/453\/Peds%20Antipsychotics%20Protocol%20Final.pdf. Accessed December 4,\u00a02013."},{"key":"10.1016\/j.jaac.2014.08.009_bib24","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1001\/jama.2009.1558","article-title":"Implications of marked weight gain associated with atypical antipsychotic medications in children and adolescents","volume":"302","author":"Varley","year":"2009","journal-title":"JAMA"},{"key":"10.1016\/j.jaac.2014.08.009_bib25","first-page":"124","article-title":"First do no harm: promoting an evidence-based approach to atypical antipsychotic use in children and adolescents","volume":"19","author":"Panagiotopoulos","year":"2010","journal-title":"J\u00a0Can Acad Child Adolesc Psychiatry"},{"key":"10.1016\/j.jaac.2014.08.009_bib26","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1097\/01.chi.0000220851.94392.30","article-title":"Endocrine and metabolic adverse effects of psychotropic medications in children and adolescents","volume":"45","author":"Correll","year":"2006","journal-title":"J\u00a0Am Acad Child Adolesc Psychiatry"},{"issue":"2 Suppl 4th Report","key":"10.1016\/j.jaac.2014.08.009_bib27","first-page":"555","article-title":"The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents","volume":"114","year":"2004","journal-title":"Pediatrics"},{"key":"10.1016\/j.jaac.2014.08.009_bib28","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1093\/clinchem\/18.6.499","article-title":"Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge","volume":"18","author":"Friedewald","year":"1972","journal-title":"Clin Chem"},{"key":"10.1016\/j.jaac.2014.08.009_bib29","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1007\/BF00280883","article-title":"Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man","volume":"28","author":"Matthews","year":"1985","journal-title":"Diabetologia"},{"key":"10.1016\/j.jaac.2014.08.009_bib30","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/S1695-4033(07)70653-7","article-title":"Prevalencia del s\u00edndrome metab\u00f3lico y sus componentes en ni\u00f1os y adolescentes con obesidad","volume":"67","author":"Tapia Ceballos","year":"2007","journal-title":"An Pediatr (Barc)"},{"key":"10.1016\/j.jaac.2014.08.009_bib31","series-title":"Curvas y tablas de crecimiento: estudios longitudinal y transversal","author":"Sobradillo","year":"2004"},{"key":"10.1016\/j.jaac.2014.08.009_bib32","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1157\/13099693","article-title":"Obesidad infantil. Recomendaciones del Comit\u00e9 de Nutrici\u00f3n de la Asociaci\u00f3n Espa\u00f1ola de Pediatr\u00eda. Parte II. Diagn\u00f3stico. Comorbilidades. Tratamiento","volume":"66","author":"Dalmau Serra","year":"2007","journal-title":"An Pediatr (Barc)"},{"key":"10.1016\/j.jaac.2014.08.009_bib33","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1038\/sj.ijo.0802787","article-title":"New insights into the field of children and adolescents' obesity: the European perspective","volume":"28","author":"Flodmark","year":"2004","journal-title":"Int J Obes Relat Metab Disord"},{"key":"10.1016\/j.jaac.2014.08.009_bib34","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1001\/archpedi.157.8.821","article-title":"Prevalence of a metabolic syndrome phenotype in adolescents: findings from the third National Health and Nutrition Examination Survey, 1988-1994","volume":"157","author":"Cook","year":"2003","journal-title":"Arch Pediatr Adolesc Med"},{"key":"10.1016\/j.jaac.2014.08.009_bib35","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1111\/j.1399-5618.2010.00797.x","article-title":"Metabolic effects of second-generation antipsychotics in bipolar youth: comparison with other psychotic and nonpsychotic diagnoses","volume":"12","author":"Moreno","year":"2010","journal-title":"Bipolar Disord"},{"key":"10.1016\/j.jaac.2014.08.009_bib36","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.biopsych.2009.08.040","article-title":"Antipsychotic dose equivalents and dose-years: a standardized method for comparing exposure to different drugs","volume":"67","author":"Andreasen","year":"2010","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.jaac.2014.08.009_bib37","first-page":"217","article-title":"Secondary effects of antipsychotic treatment in naive or quasi-naive children and adolescents: design of a follow-up protocol and baseline results","volume":"5","author":"Merchan-Naranjo","year":"2012","journal-title":"Rev Psiquiatr Salud Ment"},{"key":"10.1016\/j.jaac.2014.08.009_bib38","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1089\/cap.2010.0152","article-title":"Age-grouped differences in adverse drug events from psychotropic medication","volume":"21","author":"Safer","year":"2011","journal-title":"J\u00a0Child Adolesc Psychopharmacol"},{"key":"10.1016\/j.jaac.2014.08.009_bib39","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1097\/CHI.0b013e3181900404","article-title":"Olanzapine versus placebo in adolescents with schizophrenia: a 6-week, randomized, double-blind, placebo-controlled trial","volume":"48","author":"Kryzhanovskaya","year":"2009","journal-title":"J\u00a0Am Acad Child Adolesc Psychiatry"},{"key":"10.1016\/j.jaac.2014.08.009_bib40","doi-asserted-by":"crossref","first-page":"e771","DOI":"10.1542\/peds.2011-2158","article-title":"Antipsychotics for children and young adults: a comparative effectiveness review","volume":"129","author":"Seida","year":"2012","journal-title":"Pediatrics"}],"container-title":["Journal of the American Academy of Child & Adolescent Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0890856714005838?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0890856714005838?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T14:23:57Z","timestamp":1760192637000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0890856714005838"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,11]]},"references-count":40,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2014,11]]}},"alternative-id":["S0890856714005838"],"URL":"https:\/\/doi.org\/10.1016\/j.jaac.2014.08.009","relation":{},"ISSN":["0890-8567"],"issn-type":[{"value":"0890-8567","type":"print"}],"subject":[],"published":{"date-parts":[[2014,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Second-Generation Antipsychotic Use in Children and Adolescents: A Six-Month Prospective Cohort Study in Drug-Na\u00efve Patients","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Academy of Child & Adolescent Psychiatry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaac.2014.08.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 American Academy of Child and Adolescent Psychiatry. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}